SERTAD4 and colorectal carcinoma: Beyond studies in CRC cell lines, we conducted RT‐qPCR on 30 collected CRC tissues and discovered that SERTAD4 expression was lower in CRC tissues harbouring KRAS mutations compared to those with KRAS WT (Figure 3E, p < 0.05).